Literature DB >> 23739897

Chronic gout in the elderly.

Francesco Bolzetta1, Nicola Veronese, Enzo Manzato, Giuseppe Sergi.   

Abstract

Gout is the most common cause of inflammatory arthritis in men over 40 years old; it is a debilitating disease and, if untreated, can result in a chronic progressive disease, including tophaceous gout. In the elderly it represents a special issue, with notable clinical and therapeutic differences from the classical form with a systemic involvement. The burden of the disease increases particularly in the very old people, in whom arthritis, impaired gait and eyesight problems may enhance the related disability. Chronic gout moreover could aggravate heart and kidney disease and increase overall mortality and organ-related damage. Early diagnosis and appropriate treatment are important goals for the clinician that should to rely on the cooperation of specialists working together through the methodology of comprehensive geriatric assessment. The aim of the present review was to analyze chronic gout in old people in terms of epidemiology, pathophysiology, risk factors, clinical approach, and current treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23739897     DOI: 10.1007/s40520-013-0031-z

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  4 in total

1.  Gout Flare Burden, Diagnosis, and Management: Navigating Care in Older Patients with Comorbidity.

Authors:  Mukund Kumar; Natalie Manley; Ted R Mikuls
Journal:  Drugs Aging       Date:  2021-06-09       Impact factor: 3.923

2.  Risk factors of ultrasound-detected tophi in patients with gout.

Authors:  Beilei Lu; Qing Lu; Beijian Huang; Cuixian Li; Fengyang Zheng; Peilei Wang
Journal:  Clin Rheumatol       Date:  2020-02-15       Impact factor: 2.980

3.  Advanced erosive gout as a cause of Fever of unknown origin.

Authors:  Mikiro Kato; Yuta Oishi; Makoto Inada; Yasuharu Tokuda
Journal:  Korean J Fam Med       Date:  2015-05-22

4.  Tocilizumab improved clinical symptoms of a patient with systemic tophaceous gout who had symmetric polyarthritis and fever: An alternative treatment by blockade of interleukin-6 signaling.

Authors:  Sho Mokuda; Masamoto Kanno; Kiyoshi Takasugi; Chikara Okumura; Yuki Ito; Junya Masumoto
Journal:  SAGE Open Med Case Rep       Date:  2014-01-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.